Human Immunodeficiency Virus-Associated Dementia: An Evolving Disease

References

• Adamson DC, McArthur JC, Dawson TM, Dawson VL (1999). Rate and severity of HIV-associated dementia: corrleations with gp41 and iNOS. Mol Med 5: 98–109.
   Google Scholar
• Albert SM, Weber C, Todak G (1999). An observed perfor-mance test of medication management ability in HIV: re-lation to neuropsychological status and adherence out-comes. AIDS Behav 3: 121–128.
   Google Scholar
• Andrade A, Davis H, Celano S, Cheever L, Wu A, Skolasky RL, Letzt A, McArthur JC (2001). Intervention trial using a novel electronic device in HAART initiators: impact of cognitive dysfunction. Presented at the 8th Conference on Retroviruses and Opportunistic Infections, Feb 2–5, Chicago, IL.
   Google Scholar
• Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J (1997). Positive ef-fects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease [see comments]. Science 277: 112–116.
   PubMed Web of Science ®Google Scholar
• Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A (2001). Nonadherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 15: 1181–1183.
   PubMed Web of Science ®Google Scholar
• Barker PB, Lee RR, McArthur JC (1995). AIDS demen-tia complex: evaluation with proton MR spectroscopic imaging. Radiology 195: 58–64.
   Google Scholar
• Bartlett JG, Gallant JE (2001). Medical management of HIV infection. Baltimore, MD: Johns Hopkins University, Di-vision of Infectious Diseases.
   Google Scholar
• Bell JE, Busuttil A, Ironside JW, Rebus S, Donaldson YK, Simmonds P, Peutherer JF (1993). Human immunodefi-ciency virus and the brain: investigation of virus load and neuropathic changes in pre-AIDS subjects. J Infec Dis 168: 818–824.
   PubMed Web of Science ®Google Scholar
• Berger JR, Avison MJ (2001). Diffusion tensor imaging in HIV infection: what is it telling us? AJNR Am J Neuro-radio] 22: 237–238.
   Google Scholar
• Berger JR, Sheremata WA, Resnick L, Atherton S, Fletcher MA, Norenberg M (1989). Multiple sclerosis-like illness occurring with human immunodeficiency virus infec-tion. Neurology 39: 324–329.
   Google Scholar
• Bouwman FH, Skolasky R, Hes D, Seines OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ, McArthur JC (1998). Variable progression of HIV-associated demen-tia. Neurology 50: 1814–1820.
   Google Scholar
• Brew BJ, Bhalla RB, Fleisher M, Paul M, Kahn A, Schwartz MK, Price RW (1989). Cerebrospinal fluid beta-2 mi-croglobulin in patients infected with human immunod-eficiency virus. Neurology 39: 830–834.
   Google Scholar
• Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, Schwartz MK, Price RW (1990). Cerebrospinal fluid neopterin in human immunodeficiency virus type-I in-fection. Ann Neurol 28: 556–560.
   PubMed Web of Science ®Google Scholar
• Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson JH, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, Portegies P, McArthur JC, Symonds B, Romero C (2000). Abacavir in AIDS dementiacomplex: efficacy and lessons for future trials. Unpub-lished Work.
   Google Scholar
• Brew BJ, Pemberton L, Cunningham P, Law MG (1997). Lev-els of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 175: 963–966.
   PubMed Web of Science ®Google Scholar
• Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB (1997). Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination ther-apy. AIDS 11: 1731–1738.
   Google Scholar
• Burton G, Keele B, Estes J, Thacker T, Gartner S (2002). Fol-licular dendritic cell contributions to HIV pathogenesis. Semin Immunol 14: 275.
   Google Scholar
• Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E (1999). Cerebral metabolic abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 52: 100–108.
   PubMed Web of Science ®Google Scholar
• Chang L, Rooney W, Carasig D, Tomasi D, Zhong K, Caparelli E, Zimmerman L, Ernst T (2002). Abnormal blood-brain barrier permeability in human immunod-eficiency virus patients (abstract 282). In: Proceedings of American Neurological Association Meeting. October 13–16, New York.
   Google Scholar
• Chang L, Witt M, Eric M, Jovicich J, Ames N, Zhu W, Gaiefsky M, Ernst T (2001). Cerebral metabolite changes during the first nine months after HAART (abstract S63.001). Neurology 56: A474.
   Google Scholar
• Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore DJ, Grant I, Heaton RK (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neu-rology 59: 1563–1567.
   Google Scholar
• Chiesi A, Seeber AC, Dally LG, Floridia M, Rezza G, Vella S (1996). AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987–1993) and differ-ential incidence according to mode of transmission of HIV-1 infection. J Neurol Sci 144: 107–113.
   PubMed Web of Science ®Google Scholar
• Childs EA, Lyles RH, Seines OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC (1999). Plasma viral load and CD4 lympocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52: 607–613.
   PubMed Web of Science ®Google Scholar
• Chong WK, Paley M, Wilkinson ID, Hall-Craggs MA, Sweeney B, Harrison MJ, Miller RF, Kendall BE (1994). Localized cerebral proton MR spectroscopy in HIV in-fection and AIDS. AJNR Am J Neuromdiol 15: 21–25.
   Google Scholar
• Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kendall BE, Shepard JK, Beecham M, Miller RF, Weller IVD, Newman SP, Harrison MJG (1993). Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 188: 119–124.
   PubMed Web of Science ®Google Scholar
• Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM (2002a). A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology 59: 1568–1573.
   PubMed Web of Science ®Google Scholar
• Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM (2002b). A randomized, placebo-controlled phase II clinical trial of CPI-1189 for HIV-associated motor-cognitive impairment. Neurology 59: 1568–1573.
   PubMed Web of Science ®Google Scholar
• Cohen RA, Boland R, Paul R, Tashima KT, Schoenbaum EE, Celentano DD, Schuman P, Smith DK, Carpenter CC (2001). Neurocognitive performance enhanced byhighly active antiretroviral therapy in HIV-infected women. AIDS 15: 341–345.
   PubMed Web of Science ®Google Scholar
• Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN (1999). Cerebrospinal fluid levels of MMP-2,7, and 9 are elevated in association with human immun-odeficiency virus dementia [In Process Citation]. Ann Neurol 46: 391–398.
   Google Scholar
• Condra JH, Emini EA (1997). Preventing HIV-1 drug resis-tance. Sci Med 4: 14–23.
   Google Scholar
• Confort-Gouny S, Vion-Dury J, Nicoli F, Dano P, Gastaut JL, Cozzone PJ (1992). Metabolic characterization of neuro-logical diseases by proton localized NMR spectroscopy of the human brain. C R Acad Sci 111315: 287–293.
   Google Scholar
• Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C (1998). HIV-infected sub-jects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4: 1182–1184.
   PubMed Web of Science ®Google Scholar
• Cunningham PH, Smith DG, Satchell C, Cooper DA, Brew B (2000). Evidence for independent development of re-sistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS 14: 1949–1954.
   Google Scholar
• Dal Pan GJ, Glass JD, McArthur JC (1994). Clinicopatholog-ical correlations of HIV-1-associated vacuolar myelopa-thy: an autopsy-based case-control study. Neurology 44: 2159–2164.
   Google Scholar
• De Luca A, Ciancio BC, Larussa D, Murri R, Cingolani A, Rizzo MG, Giancola ML, A=assari A, Ortona L (2002). Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology 59: 342–347.
   Google Scholar
• Deeks SG, Abrams DI (1997). Genotypic-resistance assays and antiretroviral therapy. Lancet 349: 1489–1490.
   Google Scholar
• Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM (2001). Virologic and immunologic con-sequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Eng J Med 344: 472–480.
   PubMed Web of Science ®Google Scholar
• Donaldson YK, Bell JE, Ironside JW, Brettle RP, Robertson JR, Busuttil A, Si=onds P (1994). Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 343: 382–385.
   Google Scholar
• Dougherty RH, Skolasky RL, McArthur JC (2002). Progres-sion of HIV-associated dementia treated with HAART. AIDS Reader 12: 69–74.
   PubMedGoogle Scholar
• Dybul M, Chun T-W, Yoder C, Hidalgo B, Belson M, Hertogs K, Larder B, Dewar RL, Fox CH, Hallahan CW, Justement JS, Migueles SA, Metcalf JA, Davey RT, Daucher M, Pandya P, Baseler M, Ward DJ, Fauci AS (2001). Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: ef-fects on virologic, immunologic, and toxicity parame-ters. Proc Nati Acad Sci USA 98: 15161–15166.
   PubMed Web of Science ®Google Scholar
• Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, Abramson I, Grant I, McCutchan JA (2000). Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources [In Process Citation]. Neurol-ogy 54: 927–936.
   PubMed Web of Science ®Google Scholar
• Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA, the HIV Neurobehavioral Research Center Group (1997). Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 42: 679–688.
   PubMed Web of Science ®Google Scholar
• Ellis RJ, Moore DJ, Childers ME, Letendre S, McCutchan JA, Wolfson T, Spector SA, Hsia K, Heaton RK, Grant I (2002). Progression to neuropsychological impair-ment in human immunodeficiency virus infection pre-dicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 59: 923–928.
   Google Scholar
• Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP, Decosterd LA, Furrer H, Opravil M, Pantaleo G, Retelska D, Ruiz L, Schinkel AH, Vernazza P, Eap CB, Telenti A (2002). Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 359: 30–36.
   PubMed Web of Science ®Google Scholar
• Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J (1998). Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 12: F65–F70.
   Google Scholar
• Filippi CG, Sze G, Farber SJ, Shahmanesh M, Selwyn PA (1998). Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease in-hibitor therapy. Radiology 206: 491–498.
   Google Scholar
• Foudraine NA, Hoetelmans RM, Lange JM, de Wolf F, van Benthem BH, Maas JJ, Keet IP, Portegies P (1998). Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 351: 1547–1551.
   PubMed Web of Science ®Google Scholar
• Furrer H, Egger M, Opravil M, Bernasconi E, Hirschel B, Battegay M, Telenti A, Vernazza P, Rickenbach M, Flepp M, Malinverni R, the Swiss HIV Cohrot Study (1999). Discontinuation of primary prophylaxis against pneu-mocystis carinii penumonia in HIV-1-infected adults treated with combination antiretroviral therapy. N Eng J Med 340: 1301–1306.
   PubMed Web of Science ®Google Scholar
• Gartner S (2000). HIV infection and dementia [see com-ments]. Science 287: 602–604.
   PubMed Web of Science ®Google Scholar
• Gartner S, Liu Y (2002). Insights into the role of immune activation in HIV neuropathogenesis. J NeuroVirol 8: 69–75.
   PubMed Web of Science ®Google Scholar
• Gartner S, Liu Y, Hunter E, Sacktor N, Conant K, Pardo C, McArthur J (2000). Role of systemic events in the de-velopment of HIV encephalitis and dementia. Presented at 3rd International Symposium on Neurovirology. San Francisco, Sept 14–16.
   Google Scholar
• Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Im-munocytochemical quantitation of HIV in the brain: cor-relations with HIV-associated dementia. Ann Neurol 38: 755–762.
   PubMed Web of Science ®Google Scholar
• Glass JD, Wesselingh SL, Seines OA, McArthur JC (1993). Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43: 2230–2237.
   PubMedGoogle Scholar
• Gonzalez E, Dhanda R, Bamshad M, Mu=idi S, Geevarghese R, Catano G, Anderson SA, Walter EA, Stephan KT, Hammer MF, Mangano A, Sen L, Clark RA, Ahuja SS, Dolan MJ, Ahuja SK (2001). Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Nati Acad Sci USA 98: 5199–5204.
   Web of Science ®Google Scholar
• Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mu=idi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, Walter EA, Stephan KT, Deucher M, Mangano A, Bologna R, Ahuja SS, Dolan MJ, Ahuja SK (2002). HIV-1 infection and AIDS dementia are influ-enced by a mutant MCP-1 allele linked to increasedmonocyte infiltration of tissues and MCP-1 levels. Proc Nati Acad Sci USA 99: 13795–13800.
   PubMed Web of Science ®Google Scholar
• Griffin DE (1997). Cytokines in the brain during viral in-fection: clues to HIV-associated dementia. J Clin Invest 100: 2948–2951.
   Google Scholar
• Griffin DE, McArthur JC, Cornblath DR (1991). Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology 41: 69–74.
   PubMed Web of Science ®Google Scholar
• Griffin DE, Wesselingh SL, McArthur JC (1994). Ele-vated central nervous system prostaglandins in HIV-associated dementia. Ann Neurol 35: 592–597.
   PubMed Web of Science ®Google Scholar
• Groothuis DR, Levy RM (1997). The entry into antiviral and antiretroviral drugs into the central nervous system. J NeuroViro13: 387–400.
   Google Scholar
• Hahn MK, Blakely RD (2002). Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J 2: 217–235.
   PubMedGoogle Scholar
• Heseltine PNR, Goodkin K, Atkinson JH, Vitiello B, Rochon J, Heaton RK, Eaton EM, Wilkie FL, Sobel E, Brown SJ, Feaster D, Schneider L, Goldschmidts WL, Stover ES (1998). Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impair-ment. Arch Neurol 55: 41–51.
   PubMed Web of Science ®Google Scholar
• Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J, Rubinow D, Markey SP (1991). Quinolinic acid in cere-brospinal fluid and serum in HIV-1 infection: relation-ship to clinical and neurologic status. Ann Neurol 29: 202–209.
   PubMed Web of Science ®Google Scholar
• Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123–126.
   Google Scholar
• Hogervorst E, Jurriaans S, Dewolf F, Van Wijk A, Wiersma A, Valk M, Roos M, Vangemen B, Coutinho R, Miedema F, Goudsmit J (1995). Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection. Low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J Infec Dis 171: 811–821.
   Google Scholar
• Hriso E, Kuhn T, Masdeu JC, Grundman M (1991). Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. Am J Psy-chiatry 148: 1558–1561.
   Google Scholar
• Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK (1992). Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42: 1472–1476.
   PubMed Web of Science ®Google Scholar
• Janssen RS, Saykin AJ, Cannon L, Campbell J, Pinsky PF, Hessol NA, O'Malley PM, Lifson AR, Doll LS, Rutherford GW, et al (1989). Neurological and neu-ropsychological manifestations of HIV- 1 infection: as-sociation with AIDS-related complex but not asymp-tomatic HIV-1 infection. Ann Neurol 26: 592–600.
   PubMed Web of Science ®Google Scholar
• Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I (1993). Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 186: 739–744.
   Google Scholar
• Johnson RT, McArthur JC, Narayan 0 (1988). The neuro-biology of human immunodeficiency virus infections. FASEB J2: 2970–2981.
   Google Scholar
• Shapiro MF, Morton SC, McCaffrey DF, Senterfitt JW, Fleishman JA, Perlman JF, Athey LA, Keesey JW, Goldman DP, Berry SH, Bozzette SA (1999). Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA 281: 2305–2315.
   PubMed Web of Science ®Google Scholar
• Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, Navia BA, Petito CK, O'Hara CJ, Groopman JE, et al (1985). HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 227: 177–182.
   PubMed Web of Science ®Google Scholar
• Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K, Simpson D, Koch MA, Feinberg J, Dafni R, AIDS Clinical Trials Group (1993). Zidovudine treat-ment of the AIDS dementia complex: results of a placebo-controlled trial. Ann Neurol 33: 343–349.
   PubMed Web of Science ®Google Scholar
• Sinclair E, Gray F, Ciardi A, Scaravilli F (1994). I=unohis-tochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J Neuropathol Exp Neurol 53: 43–50.
   PubMed Web of Science ®Google Scholar
• Sinclair E, Gray F, Scaravilli F (1992). PCR detection of HIV proviral DNA in the brain of an asymptomatic HIV-positive patient (letter). J Neurol 239: 469–470.
   Google Scholar
• Sinclair E, Scaravilli F (1992). Detection of HIV proviral DNA in cortex and white matter of AIDS brains by non-isotopic polymerase chain reaction: correlation with dif-fuse poliodystrophy. AIDS 6: 925–932.
   PubMedGoogle Scholar
• Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL (1996). Determinants of compliance with antiretro-viral therapy in patients with human immunodeficiency virus: prospective assessment with implications for en-hancing compliance. AIDS Care 8: 261–269.
   Google Scholar
• Tagliati M, Simpson D, Morgello S, Clifford D, Schwartz RL, Berger JR (1998). Cerebellar degeneration associated with human immunodeficiency virus infection. Neurol-ogy 50: 244–251.
   Web of Science ®Google Scholar
• Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD (1996). Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and i=unocytochemistry. Ann Neurol 39: 705–711.
   PubMedGoogle Scholar
• The Dana Consortium on the Therapy of HIV Demen-tia and Related Cognitive Disorders (1998). A random-ized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Neurology 50: 645–651.
   Google Scholar
• The Dana Consortium on Therapy of HIV Dementia and Re-lated Cognitive Disorders (1997). Safety and efficacy of the antioxidant OPC-14117 in HIV associated cognitive impairment. Neurology 49: 142–146.
   Google Scholar
• Thomas SA, Segal MB (1997). The passage of azido-deoxythymidine into and within the central nervous system: does it follow the parent compound, thymidine? J Pharmacol Exp Ther 281: 1211–1218.
   PubMed Web of Science ®Google Scholar
• Thompson KA, McArthur JC, Wesselingh SL (2001). Corre-lation between disease progression and astrocyte apop-tosis in HIV-associated dementia. Ann Neurol 49: 745–752.
   PubMed Web of Science ®Google Scholar
• Tozzi V, Balestra P, Galgani S, Narciso P, Ferri F, Sebastiani G, D'Amato C, Affricano C, Pigorini F, Pau FM, De FeliciA, Benedetto A (1999). Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS 13: 1889–1897.
   Google Scholar
• Tsao BP (2002). the genetics of human lupus. In: Dubois' lupus mythematosus. Wallace DJ, Hahn BH (eds). Philadelphia: William & Wilkens, pp 97–120.
   Google Scholar
• Tyler KL, McArthur JC (2002). Through a glass, darkly: cere-brospinal fluid viral load measurements and the patho-genesis of human immunodeficiency virus infection of the central nervous system. Arch Neurol 59: 909–912.
   Google Scholar
• Tyor WR, Griffin JW, Wesselingh S, McArthur JC, Griffin DE (1995). A unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopa-thy, and sensory neuropathy. J Acquir Immunodefic Syndr 9: 379–388.
   Web of Science ®Google Scholar
• UNAIDS (2000). AIDS Epidemic: update, December 2000. Geneva: Joint United Nations Programme on HIV/AIDS.
   Google Scholar
• Valcour V, Shiramizu B, Shikuma C, Poff P, Watters M, Grove J, Seines O, Sacktor N (2002). Neurocogni-tive function among older compared to younger HIV-1 seropositive individuals [Abstract]. J NeuroVirol 8: 69.
   Google Scholar
• Weinshenker BG, Santrach P, Bissonet AS, McDonnell SK, Schaid D, Moore SB, Rodriguez M (1998). Major histo-compatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology51: 742–747.
   Google Scholar
• Weinshenker BG, Wingerchuk DM, Liu Q, Bissonet AS, Schaid DJ, Sommer SS (1997). Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology 49: 378–385.
   Google Scholar
• Wendell KA, McClernon DR, Lanier ER, McArthur JC (2001). Discordant HIV-1 drug resistance mutations in paired CSF and plasma. Presented at the Infectious Dis-ease Society of America Meeting, San Francisco, Oct 25–28.
   Google Scholar
• Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD (1997). In vivo compartmentalization of human immunodeficiency virus: evidence from the ex-amination of pol sequences from autopsy tissue. J Virol 71: 2059–2071.
   Google Scholar
• Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Vol-berding PA (2002). Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA 288: 222–235.
   Google Scholar
• Yiannoutsos C (2002). Patterns of regional brain meta-bolism and diagnostic utility of proton MRS in AIDS dementia complex. Unpublished work.
   Google Scholar
• Zink MC, Coleman GD, Mankowski JL, Adams RJ, Tarwater PM, Fox K, Clements JE (2001). Increased macrophage chemoattractant protein-1 in cerebrospinal fluid pre-cedes and predicts simian immunodeficiency virus en-cephalitis. J Infect Dis 184: 1015–1021.
   PubMed Web of Science ®Google Scholar
• Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak M, Jr., Spelman JP, Carter DL, Adams RJ, Lifson JD, Clements JE (1999). High viral load in the cerebrospinal fluid and brain correlates with severity of simian im-munodeficiency virus encephalitis. J Virol 73: 10480–10488.
   PubMed Web of Science ®Google Scholar